Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
16.81
+0.19 (1.14%)
Sep 2, 2026, 4:00 PM EDT - Market closed

IART Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
214.42235.05246.38276.4456.66513.45
Short-Term Investments
59.6728.6927.1932.69--
Cash & Short-Term Investments
274.08263.74273.57309.1456.66513.45
Cash Growth
8.07%-3.59%-11.49%-32.31%-11.06%9.21%
Receivables
267.19278.85272.37259.33263.47243.24
Inventory
492.01492.74429.09389.61324.58317.39
Prepaid Expenses
104.3496.097767.3685.7665.82
Other Current Assets
53.8628.1329.6532.6431.0313.82
Total Current Assets
1,1911,1601,0821,0581,1611,154
Property, Plant & Equipment
583.29584.9549.77496.38459.59396.25
Long-Term Investments
9.6512.7538.330.7140.034.37
Goodwill
611.15615.161,0971,0551,0391,013
Other Intangible Assets
1,0761,1351,2081,0681,1271,146
Long-Term Deferred Tax Assets
70.4469.8534.9246.0845.9956.95
Other Long-Term Assets
21.9425.1328.2127.4817.1612.07
Total Assets
3,5633,6024,0373,7823,8903,782

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
82.6495.7382.592.33102.161.84
Accrued Expenses
160.36164.5169.74144.71147.32186.64
Short-Term Debt
-87.8----
Current Portion of Long-Term Debt
44.5839.85607.7615.1138.1363.19
Current Portion of Leases
13.9214.0214.5415.2814.6214.78
Current Income Taxes Payable
3.243.65----
Current Unearned Revenue
11.711.4610.488.547.255.3
Other Current Liabilities
14.4438.9737.131.0111.488.28
Total Current Liabilities
330.88455.98922.13306.98320.91340.02
Long-Term Debt
1,8291,7301,1971,4861,4051,531
Long-Term Leases
162.66163.06166.93166.85157.4290.33
Long-Term Unearned Revenue
10.0611.559.19---
Pension & Post-Retirement Benefits
-13.8415.4419.3812.3125.27
Long-Term Deferred Tax Liabilities
3.475.6660.8335.3263.3445.79
Other Long-Term Liabilities
184.08178.36120.46179.31126.1964.85
Total Liabilities
2,5202,5592,4922,1942,0852,098

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.920.920.920.910.910.9
Additional Paid-In Capital
1,3461,3381,3231,3021,2771,265
Retained Earnings
423.31423.44939.92946.86879.12698.57
Treasury Stock
-686.92-689.21-691.41-647.26-362.86-234.45
Comprehensive Income & Other
-40.2-30.08-27.57-15.1110.27-45.16
Shareholders' Equity
1,0431,0431,5451,5881,8041,685
Total Liabilities & Equity
3,5633,6024,0373,7823,8903,782

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
2,0502,0351,9861,6841,6151,700
Net Cash (Debt)
-1,776-1,771-1,713-1,374-1,159-1,186
Net Cash Growth
------
Net Cash Per Share
-23.08-23.10-22.24-17.11-13.87-13.88
Filing Date Shares Outstanding
77.7777.9477.2278.2281.6483.24
Total Common Shares Outstanding
77.7877.8977.1678.1783.6584.7
Working Capital
860.6703.56159.56751.06840.59813.7
Book Value Per Share
13.4113.4020.0320.3121.5719.89
Tangible Book Value
-643.31-706.36-759.26-535.41-361.09-474.23
Tangible Book Value Per Share
-8.27-9.07-9.84-6.85-4.32-5.60
Land
-4.160.950.980.971.51
Buildings
-78.3119.7514.8614.7119.03
Machinery
-444.97405.41383.47358.14206.98
Construction In Progress
-179.61196.63137.28103.8894.85
Leasehold Improvements
-181.24179.9171.06163.34155.5
SEC Filings: 10-K · 10-Q